For General Information, page-3083

Exactly and the new team appears wonderful thus far but technically they are all still new & on trial.

I hesitated to say with all the praise ... but i wonder what those comments will be next year ?

Would hope they have all lived up to expectations but that only comes with time...

Hence incentive options ?

And many shareholders seem quick to lynch when things don't play out as expected.

Further on the repeated "they left CSL to come here" calls ....

ANP has been by steered by ex CSL for the last 20 years since listing and it is where it is today.

CG has taken the chair vacated by RM the ex CSL VP after 20 years

Success in biotech is very different to flying the nest from big pharma.

There is never any guarantees and it is always every shareholders right to question progress.